  See all
 |
Articles: Myeloproliferative Dz |
Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML
Bone Marrow Transplantation, 09/23/09
Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case—control study
The Lancet Oncology - Online First, 09/23/09 Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R
Annals of Hematology, 09/23/09 JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN)
Leukemia Research, 09/23/09 The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation
International Journal of Cancer, 09/23/09 Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience
Leukemia Research, 09/22/09 Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms
Experimental Hematology, 09/22/09 OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus
Leukemia Research, 09/22/09 Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk
Leukemia Research, 09/22/09 Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma
British Journal of Haematology, 09/21/09 PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL
Oncogene, 09/21/09 Toxicity of a second autologous peripheral blood stem cell transplant in patients with relapsed or recurrent multiple myeloma
Leukemia and Lymphoma, 09/18/09 Pomalidomide and Lenalidomide Induce p21WAF-1 Expression in Both Lymphoma and Multiple Myeloma through a LSD1-Mediated Epigenetic Mechanism
Cancer Research, 09/18/09 Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome
Leukemia and Lymphoma, 09/18/09 Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma
Cancer Treatment Reviews, 09/17/09 E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and a myeloproliferative disease
Blood, 09/17/09 Extramedullary plasmacytoma, a report of five cases diagnosed by FNAC
Cytopathology, 09/17/09 Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling
British Journal of Cancer, 09/17/09
Exclusive Author Commentary The use of novel agents in the treatment of relapsed and refractory multiple myeloma
Leukemia, 09/15/09 Proteasome inhibitors in the treatment of multiple myeloma
Leukemia, 09/15/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
188 Available Pages
|
|
